Search:  
   
 
NEWS & EVENTS
   

 

 
  Mennen Medical Receives FDA 510K for Horizon Angio-Intervention Radiology monitoring and reporting system
   
 

Mennen Medical® has received FDA approval to market its innovative Horizon Angio® patient monitoring and documentation system to the interventional cardiology and radiology market. Introducing a new dimension in patient care and documentation, Horizon Angio® is a computerized medical device that analyzes a full range of patient physiological parameters during interventional peripheral arterial analysis procedures, while performing a complete spectrum of monitoring functions.

Specifically designed for the interventional cardiologist and radiologist, the innovative system provides a cost-effective, efficient and convenient method to document and monitor all peripheral angiography procedures. Making the Horizon Angio a stand-out in the industry, its measurement and documentation capabilities include a full set of peripheral diagrams with visual stenosis depiction. These include head, neck, leg and arm right and left sides, carotid, trunk and renal diagrams.

In today's fast-paced medical environment, acquiring accurate patient data and complete electronic documentation is vital. The Horizon Angio® uses the latest patient monitoring technology and electronic documentation to meet these needs.
Statistical reporting, custom physician reports, ADT interfacing, HL7 and XML data exports are just a few of the extra tools available to make Horizon Angio an clinically significant addition to the department. Integrated with the complete line of Mennen Medical® products, the Horizon Angio® is a powerful tool for the interventional cardiologist and radiologist.
The Horizon Angio® continues Mennen Medical's forty year tradition of exciting innovation.